false 0001764046 00-0000000 0001764046 2024-05-07 2024-05-07 0001764046 us-gaap:CommonStockMember 2024-05-07 2024-05-07 0001764046 us-gaap:SeriesAPreferredStockMember 2024-05-07 2024-05-07 iso4217:USD xbrli:shares iso4217:USD xbrli:shares
 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

 

Date of report (date of earliest event reported): May 10, 2024 (May 7, 2024)

 

CLARIVATE PLC 

(Exact name of registrant as specified in its charter)

 

Jersey, Channel Islands

(State or other jurisdiction of incorporation or organization)

 

001-38911

(Commission File Number) 

 

N/A

(I.R.S. Employer Identification No.)

 

70 St. Mary Axe

London EC3A 8BE
United Kingdom

 

(Address of Principal Executive Offices)

 

(44) 207-433-4000

Registrant's telephone number, including area code

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class Trading Symbol(s) Name of each exchange on which registered
Ordinary shares CLVT New York Stock Exchange
5.25% Series A Mandatory Convertible Preferred Shares, no par value CLVT PR A New York Stock Exchange

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

 

Item 5.07.Submission of Matters to a Vote of Security Holders

 

On May 7, 2024, Clarivate Plc (“Clarivate” or the “Company”) held its 2024 Annual General Meeting of Shareholders.

 

At that meeting, the shareholders considered and acted upon three proposals pursuant to the Notice of Annual General Meeting of Shareholders and as described in more detail in the Company’s definitive proxy statement dated March 25, 2024 (the "Proxy Statement").

 

Of 668,143,386 ordinary shares outstanding and entitled to vote as of March 8, 2024 (the “Record Date”), the holders of 605,939,435 ordinary shares were present at the meeting either in person or by proxy, constituting quorum.

 

All proposals on the agenda were approved by the shareholders.

 

Below are the final voting results. In tabulating the voting results, only FOR or AGAINST votes are counted. Broker non-votes and abstentions are counted only for purposes of determining whether a quorum is present.

 

Proposal 1: Election of Directors

 

Shareholders elected the individuals named below to serve as directors of the Company, with their terms expiring at the Company’s 2025 Annual General Meeting or until their successor is duly elected and qualified. Election of each director required approval by a simple majority of the votes cast by, or on behalf of, the shareholders entitled to vote in person or represented by proxy.

 

Nominee   For   Against   Abstain   Broker Non-Votes
Andrew Snyder   567,369,521   20,239,925   34,441   18,295,548
Jonathan Gear   585,640,184   1,970,430   33,273   18,295,548
Valeria Alberola   552,696,253   34,882,276   65,358   18,295,548
Michael Angelakis   582,368,014   5,223,664   52,209   18,295,548
Jane Okun Bomba   584,555,950   3,047,888   40,049   18,295,548
Usama N. Cortas   583,025,081   4,569,295   49,511   18,295,548
Suzanne Heywood   576,841,845   10,754,939   47,103   18,295,548
Adam T. Levyn   585,606,183   1,995,319   42,385   18,295,548
Anthony Munk   552,721,820   34,862,190   59,877   18,295,548
Wendell Pritchett   542,104,109   45,069,213   470,565   18,295,548
Richard W. Roedel   546,176,223   41,407,129   60,535   18,295,548
Saurabh Saha   585,950,645   1,631,252   61,990   18,295,548

 

Proposal 2: Advisory Approval of Executive Compensation

 

Shareholders approved, on an advisory, non-binding basis, the compensation of the Company’s named executive officers as disclosed in the Proxy Statement. Approval required a simple majority of the votes cast by, or on behalf of, the shareholders entitled to vote in person or represented by proxy.

 

For   Against   Abstain   Broker Non-Votes
582,480,148   4,825,077   338,662   18,295,548

 

Proposal 3: Ratification of Appointment of Independent Registered Public Accountants

 

Shareholders ratified the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accountants for the fiscal year 2024, on a non-binding and advisory basis. Ratification required a simple majority of the votes cast by, or on behalf of, the shareholders entitled to vote in person or represented by proxy.

 

For   Against   Abstain   Broker Non-Votes
603,750,294   2,138,490   50,651   -

 

 

 

 

Item 8.01.Other Events

 

Date of 2025 Annual General Meeting of Shareholders

 

Clarivate’s 2025 Annual General Meeting of Shareholders will be held on May 7, 2025. Further details will be provided in the proxy statement for the meeting.

 

Item 9.01.Financial Statements and Exhibits

 

(d) Exhibits.

 

No.   Description
104   The cover page from this Current Report on Form 8-K formatted in Inline XBRL

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  CLARIVATE PLC
   
Date: May 10, 2024 By: /s/ Melanie D. Margolin
  Name: Melanie D. Margolin
  Title: Chief Legal Officer

 

 

 

v3.24.1.1.u2
Cover
May 07, 2024
Document Information [Line Items]  
Document Type 8-K
Amendment Flag false
Document Period End Date May 07, 2024
Entity File Number 001-38911
Entity Registrant Name CLARIVATE PLC
Entity Central Index Key 0001764046
Entity Tax Identification Number 00-0000000
Entity Incorporation, State or Country Code Y9
Entity Address, Address Line One 70 St. Mary Axe
Entity Address, City or Town London
Entity Address, Country GB
Entity Address, Postal Zip Code EC3A 8BE
City Area Code 44
Local Phone Number 207-433-4000
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Common Stock [Member]  
Document Information [Line Items]  
Title of 12(b) Security Ordinary shares
Trading Symbol CLVT
Security Exchange Name NYSE
Series A Preferred Stock [Member]  
Document Information [Line Items]  
Title of 12(b) Security 5.25% Series A Mandatory Convertible Preferred Shares, no par value
Trading Symbol CLVT PR A
Security Exchange Name NYSE
Clarivate (NYSE:CLVT)
Historical Stock Chart
Von Apr 2024 bis Mai 2024 Click Here for more Clarivate Charts.
Clarivate (NYSE:CLVT)
Historical Stock Chart
Von Mai 2023 bis Mai 2024 Click Here for more Clarivate Charts.